UPL

’s Breakup Strategy Raises Valuation Questions

announced a major restructuring to simplify its complex holding structure, but the Street reacted sharply, dragging shares down 15%. The plan involves merging Indian and global crop protection businesses into UPL Global, listing seed subsidiary Advanta separately, and eventually monetizing specialty chemicals arm Superform Chemistries. While the move aims to unlock value, investors remain wary of high debt levels and the likelihood of a steep holding company discount being applied to UPL’s valuation. Restructuring Plan - Crop protection: Indian and global businesses merged into UPL Global, with a 1:1 share swap. - Seeds: Advanta (70% subsidiary) filed for IPO; UPL to sell 8% stake. - Specialty chemicals: Superform may see PE investment before eventual listing. - Debt allocation: UPL Global to carry ~80% of net debt; UPL (holding company) the rest. - Advanta: Net debt-free. Debt Profile - Net debt: ₹23,317 crore (Dec-end). - Net debt-to-EBITDA: 2.5x. - Debt reduction not addressed in restructuring; may rely on Advanta stake sale proceeds. Investor Concerns - UPL will become a holding company, raising risk of valuation discounts. - Analysts typically apply 20–40% discounts in such structures (e.g., Grasim’s stake in UltraTech). - Current market price (~₹645) implies a 40% discount, higher than Nuvama’s 20% assumption. Valuation Scenarios - Nuvama estimates: - UPL Global: 7x EV/EBITDA FY28E, EBITDA ₹5,537 crore. - Advanta: 25x EV/EBITDA FY28E, EBITDA ₹1,203 crore. - Superform: 15x EV/EBITDA FY28E, EBITDA ₹1,882 crore. - Combined value per share: ₹816, well above current price. - Street skepticism reflects debt overhang and holding company discount risk.